CoreValve named a "Red Herring 100 Global Award" winner as "one of the top-100 tech start-ups in the world".IRVINE, Calif. -- CoreValve announced today that it has been selected as a winner in the "Red Herring Red Herring A preliminary registration statement that must be filed with the SEC describing a new issue of stock (IPO) and the prospects of the issuing company. Notes: 100 Global Award" competition. "Red Herring 100" winners and finalists from North America, Europe and Asia over the past three years were eligible for this award. The Red Herring editorial team "used a very competitive process to whittle down Verb 1. whittle down - cut away in small pieces wear away, whittle away damage - inflict damage upon; "The snow damaged the roof"; "She damaged the car when she hit the tree" this pool of 1,800 promising companies to the 100 winners of this first-time award," said Jordy Brazier of Red Herring. "Evaluations were made on both quantitative and qualitative criteria, such as innovation, management, and global strategy." The winning companies were announced and celebrated at the Red Herring Global Award event in Seattle on Dec. 3-5. "This important award recognizes that CoreValve is forging a new paradigm New Paradigm In the investing world, a totally new way of doing things that has a huge effect on business. Notes: The word "paradigm" is defined as a pattern or model, and it has been used in science to refer to a theoretical framework. for cardiovascular medicine: replacing an aortic valve aortic valve n. The valve between the left ventricle of the heart and the ascending aorta, consisting of three semilunar cusps. Aortic valve by a non-surgical transcatheter approach utilizing the Company's breakthrough ReValving[TM] System," said Jacques Seguin, M.D., Ph.D., Chairman, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Founder of CoreValve. "As a result, CoreValve is seeing a rapid technology uptake by the leading European physicians due to the ease of percutaneous implantation with the ReValving[TM] System. The procedure takes about an hour and is performed generally under local anesthesia Anesthesia, Local Definition Local or regional anesthesia involves the injection or application of an anesthetic drug to a specific area of the body, as opposed to the entire body and brain as occurs during general anesthesia. only, in a cath lab setting. While ReValving[TM] is initially focused on the highest-risk patients, there is a growing feeling among the medical community that ReValving[TM] is the procedure by which diseased aortic valves of less-sick patients will be treated in three to five years from now." About Red Herring Red Herring (www.redherring.com) is a global media company uniting the world's best high technology innovators, venture investors and business decision-makers in a variety of forums: a leading innovation-focused magazine; an online daily technology news service; technology research; and, major events for technology leaders around the globe. The magazine Red Herring provides an insider's access to the global innovation economy, featuring unparalleled insights on the emerging technologies driving the economy. About CoreValve CoreValve, Inc., is headquartered in Irvine, Calif. Its proprietary ReValving[TM] System allows both percutaneous aortic valve replacement In percutaneous aortic valve replacement (PAVR), a synthetic valve is transported to the heart through a small hole made in groin. This procedure can be compared to that performed when placing a stent, or performing balloon angioplasty. (PAVR) and transapical aortic valve replacement Aortic valve replacement is a cardiac surgery procedure in which a patient's aortic valve is replaced by a different valve. The aortic valve can be affected by a range of diseases; the valve can either become leaky (aortic insufficiency / regurgitation) or partially blocked (aortic (TAVR TAVR Territorial and Army Volunteer Reserve (British) TAVR Technical Assist Visit Report ) and is intended to provide an alternative to open-heart surgery. The ReValving[TM] System procedures are performed on the beating heart without cardiac assistance or rapid pacing, and may result in less trauma to the patient. This technology may also offer substantial cost-savings to the healthcare system. The catheter-based ReValving[TM] System includes a proprietary framed/self-expanding tissue heart valve that is specifically designed and engineered for transcatheter delivery. For more information about CoreValve, visit the Company's Web site at www.corevalve.com. (Caution: the CoreValve ReValving[TM] System will not be available in the USA for clinical trials or for sale until further notice.) |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion